2024-518535-11-00CompletedPhase 1
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 26 May 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 17 Mar 2025
- Start date
- 30 May 2025
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-518535-11-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 8
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pharma Bio-Research Group | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.